Assessing both physical and emotional functioning scales within cancer quality-of-life questionnaires at diagnosis may help predict survival in patients with lung cancer, a recent study found.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Idecabtagene vicleucel (ide-cel) led to significantly longer PFS and better therapy responses than standard regimens for patients with triple-class–exposed relapsed and refractory multiple myeloma.

Despite the approval of dupilumab (Dupixent) in September 2022, there is an ongoing dearth of clinically effective treatments for prurigo nodularis, prompting the present investigation of the monoclonal antibody for the chronic inflammatory skin condition.

In part 1 of this 2-part series on health equity in the treatment of psoriasis, Ryan Haumschild, PharmD, and Bryan Buckley, DrPH, discuss how providers can address disparities in care, specifically with race, cultural, and ethnic backgrounds in mind.

The 2021 recommendations for diabetes and prediabetes screening led to a 14.8% proportionate increase in the total US population eligible for screening, compared with the 2015 guidelines.

Payers are looking to roll back on paperwork requirements for prior authorization (PA); CMS and Medicare Advantage (MA) insurers battle over new regulations; Johnson & Johnson (J&J) falls behind Pfizer and GSK for vaccine approval.

A study conducted in China found that participants who used a smartphone application had improved insomnia severity compared with those who received sleep education.

A review based on an expert panel discussion highlights a need for the inclusion of older patients in studies of immune checkpoint inhibitors for the first-line treatment of advanced non–small cell lung cancer (NSCLC).

Hemarthropathy in multiple joints is a common feature of more severe forms of hemophilia, with the ankle joint often being reported as the main site of pain.

The FDA has granted full approval to pembrolizumab for the treatment of some patients with unresectable or metastatic microsatellite instability–high (MSI-H) or mismatch repair–deficient (dMMR) solid tumors that have progressed following previous treatment.

This study of the public health landscape in New York City investigated the interplay between social determinants of health (SDOH), chronic health conditions, and inequities in social factors, with a focus on cardiovascular disease (CVD).

Spirometry could aid physicians in identifying patients with chronic obstructive pulmonary disease (COPD) that are at high risk of cardiovascular disease, a study finds.

The ruling of Braidwood Management v Becerra puts HIV pre-exposure prophylaxis (PrEP) coverage at risk, potentially leading to more than 2000 preventable HIV infections in the coming year.

The incidence of respiratory syncytial virus (RSV)–positive acute respiratory infection (ARI) was found to be significant in the period prior to the COVID-19 pandemic in older adults.

Kathy Oubre, MS, CEO of Pontchartrain Cancer Center, discusses patient advocacy and legislative issues that will continue to define the future of community oncology.

The FDA approves over-the-counter (OTC) naloxone that will be available in late summer; the World Health Organization (WHO) might consider obesity drugs “essential” in upcoming review; the WHO updates COVID-19 vaccine recommendations.

Two posters presented at the American Academy of Dermatology (AAD) annual meeting evaluated misconceptions and addressed concerns around the use of biosimilars in dermatology.

The tool can help clinicians stratify patients into high-risk and low-risk categories.

New data underscore the long-term implications of immune-mediated thrombotic thrombocytopenic purpura (iTTP) and atypical hemolytic-uremic syndrome (aHUS), both rare diseases.

Older age was also a risk factor for hospitalization and death in patients with myeloproliferative neoplasms (MPN) who contract COVID-19, the investigators found.

Research showed that screening 10-year-old adolescents who are at high risk of type 1 diabetes (T1D) for islet autoantibodies could predict future development of T1D.

Ten states remain that have not expanded Medicaid and they are unlikely to do so; FDA was aware of contaminated infant formula months before the most recent recall; Sen. Tammy Duckworth asks the Federal Trade Commission to investigate AmeriSourceBergen over its distribution practices around the brand-name of mifepristone (Mifeprex).

Research suggests allergic diseases may increase risk of osteoarthritis (OA), for which there is currently no effective cure.

Although minimal residual disease (MRD) has emerged as a valuable prognostic marker across several hematological malignancies, its use in chronic lymphocytic leukemia (CLL) is mostly limited to clinical trials.